Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02345889 · ClinicalTrials.gov registry record · NA
A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,262
- Enrollment target
NCT02345889 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,262 participants.
The verdict
NCT02345889, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,262 participants
- Enrollment target
Study Summary
Adenoma detection rate (ADR) is a validated marker for reducing the risk of interval colorectal cancer after a screening colonoscopy. Recent studies suggest that novel devices attached to the colonoscope tip may improve the ADR of doctors performing a screening procedure
Interventions
- DEVICE Standard Colonoscopy
- DEVICE Colonoscopy with EndoCuff™
- DEVICE FUSE® Colonoscopy
- DEVICE Colonoscopy with EndoRings™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,262 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02345889
The ClinicalTrials.gov registry entry for NCT02345889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Standard Colonoscopy is the first listed.
NCT02345889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02345889 about?
NCT02345889 is a clinical study titled "A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy". Adenoma detection rate (ADR) is a validated marker for reducing the risk of interval colorectal cancer after a screening colonoscopy. Recent studies suggest that novel devices attached to the colonoscope tip may improve the ADR of doctors performing a screening procedure
What is the current status of trial NCT02345889?
This trial is currently completed. It is a NA study. The enrollment target is 1,262 participants. The study started on 2015-02. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02345889?
The interventions under investigation include: Standard Colonoscopy (DEVICE), Colonoscopy with EndoCuff™ (DEVICE), FUSE® Colonoscopy (DEVICE), Colonoscopy with EndoRings™ (DEVICE).
Who is sponsoring clinical trial NCT02345889?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.